Liam Denning is a Bloomberg Opinion columnist covering energy. A former banker, he edited the Wall Street Journal’s Heard on the Street column and wrote the Financial Times’s Lex column. Next month ...
Caris Life Sciences has transitioned to self-funded growth with positive EBITDA and free cash flow, driven by strong MI segment performance. The Roche partnership validates CAI's discovery platform, ...
Siemens (SIEGY) (SMAWF) Chief Executive Roland Busch said the company is open to further acquisitions in areas including artificial intelligence, life sciences and factory operations software, ...
Hosted on MSN
Targeted alpha therapy using astatine shows promise in thyroid cancer resistant to conventional treatment
A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, the standard beta-emitting treatment. In a first-in-human study, ...
Demon Slayer: Infinity Castle 2 might be the most highly anticipated anime film right now, but it's going to be a while until we get to see it on the big screen. After the first Demon Slayer: Infinity ...
Under-promise, over-deliver. It's a well-known and highly successful business strategy where expectations are set below what can be achieved, only to provide an outcome that vastly exceeds those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback